Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Batavia Biosciences
Batavia Biosciences
Activities:
Manufacturing
Regulatory
Pharmaceutical
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
CordenPharma & GENEPEP collaborate to leverage peptide drug substance discovery
The partnership has facilitated the expedition of the development, discovery and manufacturing of peptides for early clinical phase
ISPE announces 2024 Facility of the Year Awards category winners
The awards programme recognises pharmaceutical companies that are the 'best' in the industry for innovation, operations, digitalisation, supply chain and social impact
Tabletability, compactability and compressibility: What’s the difference?
To patients and consumers, tablets are a simple and convenient dosage form, but the science behind compressing a block of particles or granules into a single tablet can be...
Chemistry, manufacturing and control (CMC) as key drivers for drug discovery success
Embracing collaborative strategies not only accelerates drug development programmes but also fosters science-based milestone decisions, mitigates risks and prepares for...
Upcoming event
Making Pharmaceuticals
23–24 April 2024 | Exhibition | Coventry, UK
See all
Related Content
Manufacturing
Batavia enters the commercial manufacturing business
Batavia Biosciences is set to extend its CDMO services portfolio (R&D and clinical manufacturing) to include commercial manufacturing services
Manufacturing
Global alliance chooses Horizon Discovery cell line for Zika antibody
Batavia Biosciences, Vanderbilt University Medical Center (VUMC) and IDBiologics will use the cell line expression system to produce and antibody for the potent virus
Pharmaceutical
Univercells launches new vaccine manufacturing platform
Low-cost vaccine manufacturing technology, NevoLine, has been launched and already received grant for scale-up
Research & Development
Batavia partners with IAVI to advance development of vaccine against Lassa fever
The International AIDS Vaccine Initiative (IAVI) and Batavia Biosciences will work together under a grant to advance the development of a Lassa fever vaccine
Research & Development
Batavia Biosciences receives $8 million grant to develop rotavirus vaccine
Will develop a low-cost manufacturing process using novel technologies in partnership with Bio Farma
Subscribe now